Xconomy: Healthtech

Wisconsin
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult

1.
Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage | San Francisco
2.
Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus | Europe
3.
Healthcare AI Tech is Here, Now We Must Learn to Manage the Data | National
4.
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult | Wisconsin
5.
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices | Boston
6.
Five Years After Y Combinator First Admits Biotechs, They’re Dug In | San Francisco

Unpack Digital Health’s Progress & Pitfalls at X·CON on Oct. 22
Jeff Bauter Engel | Boston
Meissa Scores $30M to Test Vaccine for Dangerous Respiratory Virus
Bernadette Tansey | San Francisco
Report: IPO Activity Picking Back Up Following Quiet, Volatile Q3
Sarah de Crescenzo | San Diego
Amazon Launches Virtual Clinic to Help Its Employees Get Healthcare
Jeff Buchanan | Seattle
HMS’s $36M Deal to Buy VitreosHealth Combines Complementary Firms
Jeff Buchanan | Texas
John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
Jeff Bauter Engel | Boston
WI Watchlist: Epic, Frontdesk, Shine, StartingBlock Madison & More
Jeff Bauter Engel | Wisconsin
Boston Tech Watch: DraftKings Drives, The Engine Revs, NuTonomy Swaps
Brian Dowling | Boston
Healthcare’s Future is Telemedicine & AI, But Will Everyone Benefit?
Jeff Bauter Engel | Boston

Read More Posts ›

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!